PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.\', \'Sinovac Biotech Co., Ltd, China.\', \'National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. Electronic address: bisl@ivdc.chinacdc.cn.\', \'National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. Electronic address: shenlp@ivdc.chinacdc.cn.\', \'National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. Electronic address: wugz@ivdc.chinacdc.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0264-410X(20)30587-910.1016/j.vaccine.2020.04.070
?:doi
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 32513514
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
is ?:relation_isRelatedTo_publication of
?:title
  • The biological characteristics of SARS-CoV-2 spike protein Pro330-Leu650.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all